Es gab 50 kürzliche Insider-Transaktionen für Immunome, Inc. (IMNM), darunter 39 Käufe und 7 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $51.5M und die gesamten Insider-Verkäufe auf $2.12M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Higgins Jack, Rosett Max, Siegall Clay B. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — IMNM
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-04-02 |
Higgins Jack |
Chief Scientific Officer |
Informierter Verkauf |
9,438 |
$21.64 |
$204.24K |
22,000 |
| 2026-04-02 |
Rosett Max |
Chief Financial Officer |
Optionsausübung (Verkauf) |
39,713 |
$1.35 |
$53.61K |
- |
| 2026-03-30 |
Higgins Jack |
Chief Scientific Officer |
Schenkung (gegeben) |
6,291 |
- |
- |
31,438 |
| 2026-03-27 |
Siegall Clay B |
President and CEO |
Informierter Kauf |
25,450 |
$19.67 |
$500.6K |
690,704 |
| 2026-03-23 |
Wagenheim Philip |
Director |
Informierter Verkauf |
28,200 |
$20.65 |
$582.33K |
341,147 |
| 2026-03-20 |
Wagenheim Philip |
Director |
Informierter Verkauf |
36,800 |
$20.47 |
$753.3K |
369,347 |
| 2026-03-11 |
Bienaime Jean Jacques |
Director |
Informierter Kauf |
1,000 |
$21.55 |
$21.55K |
38,415 |
| 2026-03-10 |
Bienaime Jean Jacques |
Director |
Informierter Kauf |
1,000 |
$22.12 |
$22.12K |
37,415 |
| 2025-12-30 |
Siegall Clay B |
President and CEO |
Informierter Kauf |
4,729 |
$21.15 |
$100.02K |
665,254 |
| 2025-12-22 |
Barchas Isaac |
Director |
Informierter Verkauf |
11,251 |
$22.34 |
$251.35K |
2,031,181 |
| 2025-12-19 |
Siegall Clay B |
President and CEO |
Schenkung (gegeben) |
200,000 |
- |
- |
660,525 |
| 2025-12-19 |
Higgins Jack |
Chief Scientific Officer |
Schenkung (erhalten) |
1,000 |
- |
- |
1,000 |
| 2025-12-19 |
Tsai Philip |
Chief Technical Officer |
Informierter Kauf |
10,000 |
$20.49 |
$204.9K |
43,300 |
| 2025-12-18 |
Siegall Clay B |
President and CEO |
Informierter Kauf |
46,511 |
$21.50 |
$999.99K |
853,247 |
| 2025-09-10 |
Higgins Jack |
Chief Scientific Officer |
Optionsausübung |
22,000 |
$1.35 |
$29.7K |
40,729 |
| 2025-07-29 |
Siegall Clay B |
President and CEO |
RSU-Zuteilung |
800,000 |
$10.60 |
$8.48M |
800,000 |
| 2025-07-29 |
Stoneman Sandra G. |
Chief Legal Officer & Gc |
RSU-Zuteilung |
190,000 |
$10.60 |
$2.01M |
190,000 |
| 2025-07-29 |
Horn Kinney |
Chief Business Officer |
RSU-Zuteilung |
161,000 |
$10.60 |
$1.71M |
161,000 |
| 2025-07-29 |
Higgins Jack |
Chief Scientific Officer |
RSU-Zuteilung |
196,000 |
$10.60 |
$2.08M |
196,000 |
| 2025-07-29 |
Rosett Max |
Chief Financial Officer |
RSU-Zuteilung |
207,000 |
$10.60 |
$2.19M |
207,000 |
| 2025-07-29 |
Lechleider Robert |
Chief Medical Officer |
RSU-Zuteilung |
242,000 |
$10.60 |
$2.57M |
242,000 |
| 2025-07-29 |
Tsai Philip |
Chief Technical Officer |
RSU-Zuteilung |
190,000 |
$10.60 |
$2.01M |
190,000 |
| 2025-06-10 |
Bienaime Jean Jacques |
Director |
RSU-Zuteilung |
18,864 |
$9.57 |
$180.53K |
18,864 |
| 2025-06-10 |
Schafer Carol |
Director |
RSU-Zuteilung |
18,864 |
$9.57 |
$180.53K |
18,864 |
| 2025-06-10 |
Wagenheim Philip |
Director |
RSU-Zuteilung |
18,864 |
$9.57 |
$180.53K |
18,864 |
| 2025-06-10 |
Barchas Isaac |
Director |
RSU-Zuteilung |
18,864 |
$9.57 |
$180.53K |
18,864 |
| 2025-06-10 |
Swain Sandra M |
Director |
RSU-Zuteilung |
18,864 |
$9.57 |
$180.53K |
18,864 |
| 2025-06-10 |
Boylan James P |
Director |
RSU-Zuteilung |
18,864 |
$9.57 |
$180.53K |
18,864 |
| 2025-06-03 |
Bienaime Jean Jacques |
Director |
Informierter Kauf |
5,000 |
$9.38 |
$46.9K |
36,415 |
| 2025-03-27 |
Higgins Jack |
Chief Scientific Officer |
Optionsausübung |
5,200 |
$1.35 |
$7.02K |
18,729 |
| 2025-03-26 |
Siegall Clay B |
President and CEO |
Informierter Kauf |
137,100 |
$7.29 |
$999.46K |
806,736 |
| 2025-03-25 |
Bienaime Jean Jacques |
Director |
Informierter Kauf |
7,800 |
$7.78 |
$60.68K |
31,415 |
| 2025-03-24 |
Bienaime Jean Jacques |
Director |
Informierter Kauf |
7,000 |
$8.21 |
$57.47K |
23,615 |
| 2025-03-24 |
Tsai Philip |
Chief Technology Officer |
Informierter Kauf |
12,300 |
$8.42 |
$103.57K |
33,300 |
| 2025-01-31 |
Siegall Clay B |
President and CEO |
Informierter Kauf |
150,000 |
$7.75 |
$1.16M |
669,636 |
| 2024-11-22 |
Siegall Clay B |
President and CEO |
Informierter Kauf |
33,943 |
$9.78 |
$331.92K |
519,636 |
| 2024-11-21 |
Siegall Clay B |
President and CEO |
Informierter Kauf |
66,057 |
$9.54 |
$630.26K |
485,693 |
| 2024-11-21 |
Lechleider Robert |
Chief Medical Officer |
Informierter Kauf |
15,805 |
$9.48 |
$149.8K |
15,805 |
| 2024-11-21 |
Tsai Philip |
Chief Technology Officer |
Informierter Kauf |
21,000 |
$9.43 |
$198.03K |
21,000 |
| 2024-09-19 |
Rosett Max |
Chief Financial Officer |
Informierter Verkauf |
14,380 |
$16.01 |
$230.22K |
47,476 |
| 2024-08-19 |
Higgins Jack |
Chief Scientific Officer |
Schenkung (gegeben) |
2,471 |
- |
- |
13,529 |
| 2024-08-16 |
Bienaime Jean Jacques |
Director |
Informierter Kauf |
7,000 |
$13.94 |
$97.61K |
16,615 |
| 2024-08-15 |
Higgins Jack |
Chief Scientific Officer |
Informierter Verkauf |
3,524 |
$13.93 |
$49.07K |
16,000 |
| 2024-08-09 |
Siegall Clay B |
President and CEO |
RSU-Zuteilung |
800,000 |
$12.92 |
$10.34M |
800,000 |
| 2024-08-09 |
Stoneman Sandra G. |
Chief Legal Officer & Gc |
RSU-Zuteilung |
210,000 |
$12.92 |
$2.71M |
210,000 |
| 2024-08-09 |
Horn Kinney |
Chief Business Officer |
RSU-Zuteilung |
130,000 |
$12.92 |
$1.68M |
130,000 |
| 2024-08-09 |
Turner Bruce |
Chief Strategy Officer |
RSU-Zuteilung |
110,000 |
$12.92 |
$1.42M |
110,000 |
| 2024-08-09 |
Higgins Jack |
Chief Scientific Officer |
RSU-Zuteilung |
190,000 |
$12.92 |
$2.45M |
190,000 |
| 2024-08-09 |
Rosett Max |
EVP, Operations & CFO |
RSU-Zuteilung |
190,000 |
$12.92 |
$2.45M |
190,000 |
| 2024-08-09 |
Lechleider Robert |
Chief Medical Officer |
RSU-Zuteilung |
200,000 |
$12.92 |
$2.58M |
200,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
